136 related articles for article (PubMed ID: 27505319)
1. Circulating miR-148b-3p and miR-409-3p as biomarkers for heart failure in patients with mitral regurgitation.
Chen MC; Chang TH; Chang JP; Huang HD; Ho WC; Lin YS; Pan KL; Liu WH; Huang YK
Int J Cardiol; 2016 Nov; 222():148-154. PubMed ID: 27505319
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Circulating miR-195-3p in Heart Failure.
He X; Ji J; Wang T; Wang MB; Chen XL
Cardiology; 2017; 138(2):107-114. PubMed ID: 28618405
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the gene expression profile of peroxisome proliferator-activated receptor signaling pathway in the left atria of patients with mitral regurgitation.
Chen MC; Chang JP; Lin YS; Pan KL; Ho WC; Liu WH; Chang TH; Huang YK; Fang CY; Chen CJ
J Transl Med; 2016 Jun; 14(1):157. PubMed ID: 27250500
[TBL] [Abstract][Full Text] [Related]
4. Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis.
Wang C; Yang S; Liu CM; Jiang TT; Chen ZL; Tu HH; Mao LG; Li ZJ; Li JC
Tuberculosis (Edinb); 2018 Jan; 108():26-34. PubMed ID: 29523324
[TBL] [Abstract][Full Text] [Related]
5. Exploring the potential value of miR-148b-3p, miR-151b and miR-27b-3p as biomarkers in acute ischemic stroke.
Cheng X; Kan P; Ma Z; Wang Y; Song W; Huang C; Zhang B
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361294
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study.
Cakmak HA; Coskunpinar E; Ikitimur B; Barman HA; Karadag B; Tiryakioglu NO; Kahraman K; Vural VA
J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):431-7. PubMed ID: 25643195
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: A genome-wide prospective study.
Scrutinio D; Conserva F; Passantino A; Iacoviello M; Lagioia R; Gesualdo L
J Heart Lung Transplant; 2017 Jun; 36(6):616-624. PubMed ID: 28259597
[TBL] [Abstract][Full Text] [Related]
8. Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approaches.
Ghoreishi E; Shahrokhi SZ; Kazerouni F; Rahimipour A
BMC Endocr Disord; 2022 Aug; 22(1):207. PubMed ID: 35978298
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive microRNA profiling reveals potential augmentation of the IL1 pathway in rheumatic heart valve disease.
Lu Q; Sun Y; Duan Y; Li B; Xia J; Yu S; Zhang G
BMC Cardiovasc Disord; 2018 Mar; 18(1):53. PubMed ID: 29548280
[TBL] [Abstract][Full Text] [Related]
10. Differential Gene Expression Profile of Renin-Angiotensin System in the Left Atrium in Mitral Regurgitation Patients.
Liu WH; Fang YN; Wu CC; Chen MC; Chang JP; Lin YS; Pan KL; Ho WC; Chang TH; Huang YK; Fang CY; Chen CJ; Lee WC
Dis Markers; 2018; 2018():6924608. PubMed ID: 30581499
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levels.
Sandrim VC; Luizon MR; Palei AC; Tanus-Santos JE; Cavalli RC
BJOG; 2016 Dec; 123(13):2120-2128. PubMed ID: 26853698
[TBL] [Abstract][Full Text] [Related]
12. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
13. Investigating gene-microRNA networks in atrial fibrillation patients with mitral valve regurgitation.
Larupa Santos J; Rodríguez I; S Olesen M; Hjorth Bentzen B; Schmitt N
PLoS One; 2020; 15(5):e0232719. PubMed ID: 32392228
[TBL] [Abstract][Full Text] [Related]
14. miR-148b-3p affects the pathogenesis of adjuvant-induced arthritis rats through the direct target DNMT1.
Miao C; Yu H; Chang J; Zhang G; Zhou G; Zhao C
Autoimmunity; 2018 Mar; 51(2):43-52. PubMed ID: 29475367
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis.
Wang WT; Zhao YN; Han BW; Hong SJ; Chen YQ
J Clin Endocrinol Metab; 2013 Jan; 98(1):281-9. PubMed ID: 23118427
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients.
Ellis KL; Cameron VA; Troughton RW; Frampton CM; Ellmers LJ; Richards AM
Eur J Heart Fail; 2013 Oct; 15(10):1138-47. PubMed ID: 23696613
[TBL] [Abstract][Full Text] [Related]
17. The transcardiac gradient of cardio-microRNAs in the failing heart.
Marques FZ; Vizi D; Khammy O; Mariani JA; Kaye DM
Eur J Heart Fail; 2016 Aug; 18(8):1000-8. PubMed ID: 27072074
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs in obese and lean heart failure patients: A case-control study with computational target prediction analysis.
Thomé JG; Mendoza MR; Cheuiche AV; La Porta VL; Silvello D; Dos Santos KG; Andrades ME; Clausell N; Rohde LE; Biolo A
Gene; 2015 Dec; 574(1):1-10. PubMed ID: 26211628
[TBL] [Abstract][Full Text] [Related]
19. Identification of cardiac-related circulating microRNA profile in human chronic heart failure.
Li H; Fan J; Yin Z; Wang F; Chen C; Wang DW
Oncotarget; 2016 Jan; 7(1):33-45. PubMed ID: 26683101
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide sequencing and quantification of circulating microRNAs for dogs with congestive heart failure secondary to myxomatous mitral valve degeneration.
Jung S; Bohan A
Am J Vet Res; 2018 Feb; 79(2):163-169. PubMed ID: 29359980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
